Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for MRNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 6.761B
March 31, 2026 7.408B
December 31, 2025 8.65B
September 30, 2025 9.33B
June 30, 2025 9.399B
March 31, 2025 10.07B
December 31, 2024 10.90B
September 30, 2024 11.93B
June 30, 2024 11.71B
March 31, 2024 12.82B
December 31, 2023 13.85B
September 30, 2023 13.46B
June 30, 2023 16.95B
March 31, 2023 18.86B
December 31, 2022 19.12B
September 30, 2022 17.99B
June 30, 2022 17.98B
March 31, 2022 17.08B
Date Value
December 31, 2021 14.14B
September 30, 2021 10.12B
June 30, 2021 6.704B
March 31, 2021 3.838B
December 31, 2020 2.561B
September 30, 2020 2.760B
June 30, 2020 2.947B
March 31, 2020 1.641B
December 31, 2019 1.175B
September 30, 2019 1.252B
June 30, 2019 1.339B
March 31, 2019 1.446B
December 31, 2018 1.530B
September 30, 2018 1.076B
June 30, 2018
March 31, 2018
December 31, 2017 625.30M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
BioNTech SE 20.30B
Kailera Therapeutics, Inc. 1.118B
Sarepta Therapeutics, Inc. 1.528B
Replimune Group, Inc. 105.64M
Intellia Therapeutics, Inc. 727.71M

Shareholders Equity (Quarterly) Related Metrics